American Head And Neck Society (AHNS) 10th International Conference on Head and Neck Cancer

American Head And Neck Society (AHNS) 10th International Conference on Head and Neck Cancer is organized by the American Head And Neck Society. The session is held from Jul 18 - 22, 2020 at Hyatt Regency Chicago, Chicago, Illinois, United States of America.

Targeted Audience
• Head and Neck Surgeons
• Otolaryngologists
• Plastic Surgeons
• Surgical and Medical Oncologists
• Dentists & Oral Surgeons
• Radiation Oncologists
• Radiologists
• Pathologists
• Residents and Fellows
• Clinical Investigators
• Molecular and Cellular Biologists
• Advanced Practice Providers
• Speech and Language Pathologists
• Allied Health Professionals

Learning Objectives:
By the end of the session, attendees must be able to,
• Assess and apply therapeutic options for the head and neck, salivary gland, and thyroid cancer patient in a multidisciplinary environment, including:
? Induction chemotherapy and concurrent chemoradiotherapy, and how these treatments impact oncologic and functional outcomes of a patient with advanced head and neck cancer;
? Novel radiation delivery, and the benefits and shortcomings of methods such as Intensity Modulated Radiotherapy (IMRT) with comparison to proton therapy;
? Emerging molecular-targeted agents, and their efficacy and role in the treatment of head and neck cancer, including thyroid cancer.
? Surgical treatments, including the impact of breakthroughs in technology leading to robotic surgery, endoscopic approaches to the neck and thyroid gland, image-guided treatment of skull base neoplasms, sentinel node mapping
? Advances in radiology and imaging will be reviewed: Describe approaches to reduce sampling error in during surgery or pathological assessment of the tumor specimen of pre-operative and post-operative optical imaging technologies
? Review of new reconstructive surgical approaches and examine with conventional strategies to compare the outcomes, cost, and latest innovative instrumentation and hemostatic devices

• Estimate arising researches that pave to better recognition of the pathogenesis of head and neck cancer and its treatment that includes,
? FInding Breakthrough approaches for disease detection, pre-treatment staging, and assessment of treatment response.
? Eminent throughput laboratory methods to diagnose tumors and biofluids that include whole-genome sequencing, cDNA microarrays, array CGH, SNP arrays, and integrative genomics
? The importance of human papillomavirus elements and or antibodies in tumors and biofluids
? Pre-clinical evaluation of novel therapeutics
? Quick detection of oral pre-malignancy cancer and chemopreventive strategies
? Recently discovered biomarkers and their utility in treatment selection
? In addition, participants with research careers may also be able to find new collaborators, develop new research protocols (including clinical trials), and participate in enhancing the existing protocols and trials

• Assess and apply the process, outcomes, and quality of delivering care to head and neck cancer patients, including:
? The value of treatment guidelines including the NCCN treatment guidelines in improving patient care
? How to measure patient-reported outcomes and maximize their utility
? How to establish a surgical quality and performance monitoring program
? How cost-effectiveness is important to consider in considering novel treatments
? The Physician Quality Reporting Initiative (PQRI) in head and neck cancer care
? Incorporating quality into trainee/medical student education
? The burden of caring for H&N cancer in the developing and international community
Recognize the vital role of nurses, speech-language pathologists, audiologists, nutritionists, social workers, pain specialists, mental health practitioners, physical therapists, dental oncologists in achieving maximal functional outcomes and increase interdisciplinary cooperation.

Additional details will be posted as soon as information is available